🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

5.977.099

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 3 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
15/06/2026 0,8200 USD
13/03/2026 0,8200 USD
15/12/2025 0,7900 USD
15/09/2025 0,7900 USD
13/06/2025 0,7900 USD
14/03/2025 0,7900 USD
13/12/2024 0,7700 USD
13/09/2024 0,7700 USD
14/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7500 USD
14/09/2023 0,7500 USD
14/06/2023 0,7500 USD
14/03/2023 0,7500 USD
14/12/2022 0,7300 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
11/11/2014 107,48 108,72 106,67 108,01 +0,93% 1,91% 12.206.500
10/11/2014 109,07 109,37 106,66 107,02 +0,54% 2,48% 21.412.900
07/11/2014 108,90 108,95 106,33 106,45 -0,46% 2,41% 12.663.700
06/11/2014 106,94 108,45 106,10 106,94 +0,84% 2,20% 13.149.400
05/11/2014 110,87 110,91 105,75 106,05 -3,34% 4,65% 15.459.500
04/11/2014 109,62 110,65 108,97 109,72 -0,24% 1,53% 10.206.800
03/11/2014 112,31 112,80 108,81 109,98 -1,80% 3,55% 15.356.600
31/10/2014 115,90 116,83 110,76 112,00 -1,94% 5,24% 22.070.000
30/10/2014 110,72 114,35 110,60 114,22 +3,16% 3,39% 13.796.700
29/10/2014 109,85 113,43 108,00 110,72 -2,41% 4,94% 21.151.500
28/10/2014 113,25 114,13 112,26 113,45 +0,76% 1,65% 16.128.700
27/10/2014 110,77 112,99 108,87 112,59 +1,70% 3,72% 11.505.500
24/10/2014 107,53 111,47 106,60 110,71 +3,29% 4,53% 15.125.700
23/10/2014 106,64 108,18 105,50 107,18 +1,03% 2,51% 13.872.600
22/10/2014 106,51 107,00 104,08 106,09 -0,54% 2,74% 13.763.100
21/10/2014 104,05 106,67 103,46 106,67 +4,36% 3,09% 12.267.900
20/10/2014 101,15 103,59 100,82 102,21 +1,45% 2,74% 11.887.100
17/10/2014 98,62 102,32 98,62 100,75 +3,99% 3,75% 17.539.000
16/10/2014 94,39 100,00 93,28 96,88 +0,75% 7,12% 19.881.400
15/10/2014 95,00 97,77 91,73 96,16 -1,05% 6,36% 23.835.100
14/10/2014 102,00 102,88 94,27 97,18 -4,20% 8,44% 27.245.100
13/10/2014 104,49 104,57 101,36 101,44 -2,21% 3,07% 14.578.900
10/10/2014 105,39 107,50 103,00 103,73 -2,00% 4,27% 19.704.500
09/10/2014 108,42 108,62 105,72 105,85 -2,77% 2,67% 13.174.600
08/10/2014 104,30 108,97 104,04 108,87 +4,39% 4,73% 16.545.000
07/10/2014 104,85 105,30 102,54 104,29 -0,80% 2,63% 9.757.300
06/10/2014 107,22 107,45 104,82 105,13 -1,30% 2,45% 11.278.300
03/10/2014 105,55 107,35 104,71 106,52 +1,87% 2,50% 10.294.700
02/10/2014 105,00 105,91 103,61 104,56 -0,98% 2,19% 11.527.500
01/10/2014 106,99 107,59 105,19 105,59 -0,81% 2,24% 11.659.400